Evaluation of PUVA-induced skin side effects in patients referred to the Imam Reza Hospital of Mashhad in 2005-2007
Open Access
- 1 January 2014
- journal article
- research article
- Published by Medknow in Indian Journal of Dermatology
- Vol. 59 (2) , 209
Abstract
Background: Systemic oral psoralens plus UVA therapy (PUVA) is a therapeutic method used with considerable success in many different skin disorders. PUVA therapy causes some cutaneous and noncutaneous side effects and in the present research we deal with cutaneous side effects. Aims: Evaluation of patients to know the different skin side effects of PUVA and their importance. Materials and Methods: All patients referred to the phototherapy unit of Imam Reza Hospital of Mashhad entered the research and skin examination was taken place initially and every 3 months thereafter. Whenever any side effect appeared, it was recorded in the information sheet. Results: One hundred and twenty-eight patients were included in the research, 61 were male between 15 and 75 years and 67 were female between 10 and 61 years of age. Age of female patients at the time of cutaneous side effect appearance was less than male patients. The most common early side effect was pruritus (34.3%) and the rarest was telangiectasia (0.7%). One case of late side effect in the form of squamous cell carcinoma was observed in a patient who had received other carcinogenic drugs as well. Complications such as skin dryness, pruritus, erythema and burning sensation occurred at low doses of UVA, while dermatitis, severe limb pain and acne at moderate doses and PUVA lentigines, hypertrichosis and lichenoid lesions appeared at high doses of UVA. Conclusion: Considering the significant therapeutic effects and few serious side effects, PUVA therapy is a suitable and safe method for treatment of certain skin diseases.Keywords
This publication has 15 references indexed in Scilit:
- Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeksJournal of the American Academy of Dermatology, 2009
- Effect of PUVA, narrow‐band UVB and cyclosporin on inflammatory cells of the psoriatic plaqueJournal of Cutaneous Pathology, 2006
- Randomized Double-blind Trial of the Treatment of Chronic Plaque PsoriasisArchives of Dermatology, 2006
- Psoralen ultraviolet A therapy in 2004Photodermatology, Photoimmunology & Photomedicine, 2004
- A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasisJournal of the American Academy of Dermatology, 1999
- PhotochemotherapyClinics in Dermatology, 1997
- Psoralens and UV-A-induced stellate hyperpigmented freckling.1982
- Nevus spilus-like hyperpigmentation in psoriatic lesions during PUVA therapyActa Dermato-Venereologica, 1980
- Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light systemArchives of Dermatology, 1976
- Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet LightNew England Journal of Medicine, 1974